Cure Pharmaceutical


Cure Pharmaceutical specializes in researching, innovating, and manufacturing unique, patented orodispersible dosage forms that enhance patient compliance and accessibility. They focus on creating innovative process technology platforms to improve the effectiveness and utility of existing molecules, aiming to avoid first pass metabolism, improve absorption, and provide convenience and safety. Their mission is to develop advanced drug delivery systems, such as the CUREFilm®, to address issues with traditional oral delivery, improve patient adherence, and expand treatment options across various markets including pharmaceuticals, vaccines, nutraceuticals, and underserved populations.

Industries

biotechnology
cannabis
manufacturing
pharmaceutical

Nr. of Employees

small (1-50)

Cure Pharmaceutical

Oxnard, California, United States, North America


Products

Oral thin-film formulation containing sildenafil citrate

An oral thin-film dosage form containing sildenafil citrate designed for rapid dissolution and faster systemic absorption compared with tablets.

Oral thin-film insulin formulation

An oral thin-film insulin candidate intended as a needle-free alternative to injectable insulin.

Oral thin-film vaccine candidates (e.g., hepatitis B)

Oral thin-film formulations being developed as vaccine candidates, including an oral hepatitis B vaccine approach.

Nutraceutical oral thin-film products

Nutraceutical products formulated as oral thin films for consumer and health markets.


Services

Formulation and product development for oral thin films

R&D services to develop orodispersible/oral thin-film formulations for small molecules, vaccines, biologics, and nutraceuticals.

cGMP manufacturing and scale-up services

Contract manufacturing and process scale-up within an FDA-registered, cGMP-certified facility for oral thin-film products.

Intellectual property and licensing support

Management of patent portfolio and IP-related activities for thin-film delivery technologies and potential licensing opportunities.

Expertise Areas

  • Oral thin-film drug delivery
  • Formulation development for sublingual/buccal routes
  • cGMP pharmaceutical manufacturing and scale-up
  • Vaccine and biologic oral formulation
  • Show More (4)

Key Technologies

  • Oral thin-film (orodispersible) formulation
  • Sublingual/buccal delivery
  • Rapid-dissolve film technology
  • Room-temperature-stable formulations
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.